{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16665",
      "entity_text" : "HIF-1alpha",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0115" ],
      "CellType" : [ "cl:CL:0000746" ],
      "Species" : [ "taxonomy:9986" ]
    }
  },
  "verbose_text" : "XREF_BIBR, XREF_BIBR In a study of the effect of levosimendan on HIF-1alpha activation, Li Yongwang found that the HIF-1alpha activation level in the observation group improved more significantly than that in the control group, indicating that levosimendan can significantly inhibit HIF-1alpha activation.",
  "reading_complete" : "2020-08-09T19:37:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T19:36:27Z",
  "trigger" : "level",
  "evidence" : [ "HIF-1alpha activation level" ],
  "pmc_id" : "6567749",
  "score" : 0
}